The core business model of Charles River Laboratories revolves around providing critical outsourced products and scientific services to the global healthcare and pharmaceutical industries. Its operations are divided into primary segments: Research Models and Services, which supplies standardized laboratory research models; Discovery and Safety Assessment, which conducts rigorous preclinical testing; and Manufacturing Solutions, which delivers microbial quality control and cell therapy production.